» Articles » PMID: 21906393

Gut Flora Enhance Bacterial Clearance in Lung Through Toll-like Receptors 4

Overview
Journal J Biomed Sci
Publisher Biomed Central
Specialty Biology
Date 2011 Sep 13
PMID 21906393
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The influence of the gut flora on lung inflammatory reaction against bacterial challenge remains undefined. This study was designed to investigate whether gut flora enhances lung defense against E.coli pneumonia through TLR4 signaling.

Methods: C3H/HeN (WT) mice and C3H/HeJ (TLR4 deficient) mice were treated with antibiotics in drinking water for 4 weeks to deplete gut commensal microflora. At week 3, drinking water was supplemented with lipopolysaccharide (LPS); a ligand for TLR4, to trigger TLRs in intestinal tract. At the end of 4th week, E.coli was injected to trachea to induce E.coli pneumonia.

Results: We found that commensal depletion by antibiotic pretreatment before E.coli pneumonia challenge induced a 30% decrease of MPO activity in the lung, a significant decrease of bacterial killing activity of alveolar macrophage, and bacterial counts in C3H/HeN mice but not in C3H/HeJ (TLR4 deficient) mice. LPS, a TLR4 ligand, supplementation during antibiotic pretreatment reversed these effects and decreased E.coli pneumonia-induced mortality in C3H/HeN mice. Furthermore, commensal depletion induced a suppression of NF-κB DNA binding activity and an increase of KC, MIP-2, IL-1β expression in the lung in C3H/HeN mice but not in C3H/HeJ mice.

Conclusions: Taken together with that commensal depletion increased E.coli pneumonia-induced mortality and LPS supplementation decreased it, we conclude that gut flora enhances bacterial clearance against E.coli pneumonia through TLR4.

Citing Articles

The role of the early-life gut microbiome in childhood asthma.

Boulund U, Thorsen J, Trivedi U, Tranaes K, Jiang J, Shah S Gut Microbes. 2025; 17(1):2457489.

PMID: 39882630 PMC: 11784655. DOI: 10.1080/19490976.2025.2457489.


Air-Pollution-Mediated Microbial Dysbiosis in Health and Disease: Lung-Gut Axis and Beyond.

Mazumder M, Hussain S J Xenobiot. 2024; 14(4):1595-1612.

PMID: 39449427 PMC: 11503347. DOI: 10.3390/jox14040086.


Alveolar macrophage modulation via the gut-lung axis in lung diseases.

Chen Z, Liu Y, Huang W Front Immunol. 2023; 14:1279677.

PMID: 38077401 PMC: 10702770. DOI: 10.3389/fimmu.2023.1279677.


The respiratory microbiota and its impact on health and disease in dogs and cats: A One Health perspective.

Vientos-Plotts A, Ericsson A, Reinero C J Vet Intern Med. 2023; 37(5):1641-1655.

PMID: 37551852 PMC: 10473014. DOI: 10.1111/jvim.16824.


The Function and Molecular Mechanism of Commensal Microbiome in Promoting Malignant Progression of Lung Cancer.

Wang H, Hu J, Wu J, Ji P, Shang A, Li D Cancers (Basel). 2022; 14(21).

PMID: 36358812 PMC: 9658664. DOI: 10.3390/cancers14215394.


References
1.
Sadikot R, Zeng H, Joo M, Everhart M, Sherrill T, Li B . Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. J Immunol. 2006; 176(8):4923-30. DOI: 10.4049/jimmunol.176.8.4923. View

2.
Neurath M, Becker C, Barbulescu K . Role of NF-kappaB in immune and inflammatory responses in the gut. Gut. 1998; 43(6):856-60. PMC: 1727350. DOI: 10.1136/gut.43.6.856. View

3.
Chen L, Chen P, Hsu C . Commensal microflora contribute to host defense against Escherichia coli pneumonia through Toll-like receptors. Shock. 2011; 36(1):67-75. DOI: 10.1097/SHK.0b013e3182184ee7. View

4.
Mizgerd J . Acute lower respiratory tract infection. N Engl J Med. 2008; 358(7):716-27. PMC: 2711392. DOI: 10.1056/NEJMra074111. View

5.
Medzhitov R . Toll-like receptors and innate immunity. Nat Rev Immunol. 2002; 1(2):135-45. DOI: 10.1038/35100529. View